Experion is a Canadian licensed producer of premium cannabis focused on growing craft high quality strains within a state of the art facility skilled at maneuvering the regulatory environment, getting products into the market for distribution and building brand recognition. Is there opportunity? Plenty.

There has never been a better time:

  • Cannabis consumers are projected to spend U.S. $5.2 billion in Canada by 2024

  • The medical marijuana market in Canada has the potential to be U.S. $1.88 billion by 2025

  • Global cannabis spending is expected to reach U.S. $66.3 billion by the end of 2025

  1. Investor Presentation
  2. Global Investor Forum
  3. Contact Investor Relations

Current markets


  • $0.3900

    CURRENT ($)

  • 0.03

    24-hour Change ($)

  • 8.33%

    24-hour Change (%)

Category Leading Brands For Everyone

  • Creating premium handcrafted cannabis products for all consumer needs

  • Adult use

    Small batch handcrafted cannabis grown organically by Canada’s leading cultivation team consistently delivering high levels of THC and CBD

  • Therapeutic

    Pills and topicals designed to mitigate chronic pain and improve user lifestyle so you can focus on what you care about

  • Medical

    Direct to patient sales of high quality flower and CBD pills utilizing advanced encapsulation technology that delivers precise micro-dosing

An established and growing
global presence

We should mention not only the emerging markets here, but hopefully the partnerships already secured in those markets.

Experion advantages

State-of-the-art facilities, scientific research, and key partnerships give Experion the clear upper hand.

  • Advanced facility

    Traditional growing in a GMP capable state of the art cultivation and processing facility supported by Canada's premier cultivation experts

  • Research

    Developing a bank of over 60 genetic strains and administering Canada's first Stage 3 clinical trial for pain management with cannabis

  • Partnerships

    Driving shareholder value through productive partnerships with only the best cannabis producers, discerning retailers and innovative manufacturers

  • Global export

    Expertise, skill set and network to take advantage of global export opportunities

Press releases

  • Serenas’ legal claims fully resolved against Experion Holdings Ltd. and Experion Biotechnologies Inc.

    December 19th, 2019

  • Experion Continues to Lead the Handcrafted Cannabis Industry

    December 4th, 2019

  • Experion’s Head Grower of Award Winning Citizen Stash Brand Nominated for the 2019 Cannabis Awards as Top Master Grower

    October 28th, 2019

  • Experion Holdings Ltd Successfully Obtains DTC Eligibility for its Common Shares

    October 17th, 2019

  • Experion Provides Update on Commercial and Operations Activities

    September 25th, 2019

  • Experion Partners with Leading Hemp Supplier to Secure Access to Hemp-based CBD

    September 17th, 2019

Public filings

The numbers

  • $5.2B

    Projected spend Adult-use cannabis in Canada by 2024 (USD)

  • $1.88B

    Potential size of the Medical marijuana market in Canada by 2025 (USD)

  • $2.03B

    Expected Canadian market size for alternative cannabis products annually starting 2020 (USD)

  • $66.3B

    Global cannabis spend by the end of 2025 (USD)


As the world continues to shift towards the legalization of cannabis, Experion has a unique advantage to distribute high quality flower and therapeutic products on a global platform


    Optimize cultivation and processing capacity internally and with grow partners


    Expand distribution and deepen brand awareness


    Develop continuous rotation of premium high-quality cannabis strains for launch


You must be of legal age in accordance with the law of your province to access this website and/or to purchase cannabis. By entering this site you agree to our terms and conditions and privacy policy.